Get the Stockscreener App
0.88
0.00%
0.00
After Hours:
.88
Moolec Science Sa stock is traded at $0.88, with a volume of 5,428.
It is up +0.00% in the last 24 hours and down -1.11% over the past month.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.
See More
Previous Close:
$0.88
Open:
$0.8584
24h Volume:
5,428
Relative Volume:
0.25
Market Cap:
$33.75M
Revenue:
-
Net Income/Loss:
$-6.48M
P/E Ratio:
-0.6542
EPS:
-1.3451
Net Cash Flow:
$-12.79M
1W Performance:
+2.92%
1M Performance:
-1.11%
6M Performance:
-26.67%
1Y Performance:
-63.56%
1-Day Range:
$0.85
$0.8842
1-Week Range:
$0.83
$0.912
52-Week Range:
$0.75
$3.25
Moolec Science Sa Stock (MLEC) Company Profile
Compare MLEC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MLEC
Moolec Science Sa
|
0.88 | 33.75M | 0 | -6.48M | -12.79M | -1.3451 |
|
VRTX
Vertex Pharmaceuticals Inc
|
464.56 | 119.70B | 10.63B | -479.80M | -1.35B | 13.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
754.87 | 82.75B | 13.85B | 4.65B | 3.32B | 35.06 |
|
ARGX
Argen X Se Adr
|
614.59 | 36.73B | 1.86B | -40.29M | -1.28B | -4.16 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.74 | 32.53B | 2.09B | -332.26M | 16.06M | -4.14 |
|
BNTX
Biontech Se Adr
|
120.72 | 28.50B | 3.30B | -501.07M | 1.03B | 11.54 |
Moolec Science Sa Stock (MLEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-27-23 | Initiated | ROTH MKM | Buy |
Moolec Science Sa Stock (MLEC) Latest News
Contrasting Moolec Science (MLEC) and Its Rivals - Defense World
Head-To-Head Contrast: Moolec Science (MLEC) & Its Rivals - Defense World
Head to Head Review: Moolec Science (MLEC) vs. Its Rivals - Defense World
Comparing Moolec Science (MLEC) and Its Peers - Defense World
Moolec Science (MLEC) and Its Peers Critical Comparison - Defense World
Head-To-Head Contrast: Moolec Science (MLEC) vs. Its Competitors - Defense World
Moolec Science (MLEC) vs. The Competition Head-To-Head Contrast - Defense World
Moolec Becomes First Molecular Farming Company to Achieve USDA A - GuruFocus.com
Analyzing Moolec Science (MLEC) & Its Rivals - Defense World
Moolec Science (MLEC) versus Its Competitors Critical Review - Defense World
Moolec Science to Host Second Quarter Fiscal Year 2024 Business Update Conference Call - GuruFocus.com
Moolec Science (MLEC) versus Its Rivals Head-To-Head Comparison - Defense World
Moolec Confirms US Harvest and Promising Yields for Plant-Grown - GuruFocus.com
Analyzing Moolec Science (MLEC) & The Competition - Defense World
Critical Review: Moolec Science (MLEC) & Its Competitors - Defense World
Moolec Has Received USDA Approval for the First Genetically Modified Pea in History - ACN Newswire
Contrasting Moolec Science (MLEC) and Its Competitors - Defense World
Biotech Wants Vegetarians to Eat Its Peas Spliced With Beef DNA - Bloomberg
Financial Analysis: Moolec Science (NASDAQ:MLEC) versus Thunder Bridge Capital Partners IV (NASDAQ:THCP) - Defense World
Moolec Science gains USDA nod for iron-rich GE peas By Investing.com - Investing.com South Africa
Moolec Science gains USDA nod for iron-rich GE peas - Investing.com India
Moolec Science (MLEC) and Its Competitors Head to Head Review - Defense World
Head-To-Head Survey: Moolec Science (MLEC) vs. Its Rivals - Defense World
Moolec Science SA (MLEC) Q4 2024 Earnings Call Transcript Highlights: Revenue Surge and ... By GuruFocus - Investing.com Canada
Moolec Science Full Year 2024 Earnings: US$0.19 loss per share (vs US$1.50 loss in FY 2023) - Yahoo Finance
Moolec Science Presents First Quarter Fiscal Year 2024 Business Update, Business Wires News - AsiaOne
Moolec Science price target lowered to $3 from $6 at Maxim - TipRanks
Maxim Group cuts Moolec Science stock price target, keeps Buy rating - Investing.com
Moolec Science (NASDAQ:MLEC) Issues Earnings Results, Misses Expectations By $0.01 EPS - Defense World
Earnings call: Moolec Science reports growth, sets sights on 2025 milestones - Investing.com
Moolec Science Presents Fiscal Year 2024 Annual Business Update - Newswire
Moolec Science reports FY24 EPS (19c) vs. ($1.50) last year - TipRanks
Moolec Science SA (MLEC) Q4 2024: Everything You Need To Know Ah - GuruFocus.com
Moolec Science (MLEC) Scheduled to Post Earnings on Wednesday - Defense World
Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call - PharmiWeb.com
Moolec Science (NASDAQ:MLEC) Shares Down 6.5% - Defense World
Moolec Received NASDAQ Bid Price Letter - Milton Daily Standard
Moolec Science Faces Nasdaq Compliance Challenge - TipRanks
Moolec Science (NASDAQ:MLEC) Stock Quotes, Forecast and News Summary - Benzinga
Moolec Confirms US Harvest and Promising Yields for Plant-Grown Products GLASO(TM) and Piggy Sooy(TM) in October - Yahoo Finance UK
Moolec Confirms US Harvest and Promising Yields for Plant-Grown Products GLASO™ and Piggy Sooy™ in October - Newswire
Financial Analysis: Moolec Science (NASDAQ:MLEC) versus Fifth Wall Acquisition Corp. III (NASDAQ:FWAC) - Defense World
Comparing Moolec Science (NASDAQ:MLEC) & Ross Acquisition Corp II (NYSE:ROSS) - Defense World
Moolec Science Sa Stock (MLEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):